Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000090

CEO bought 13,340 shares at an average $0.13 ($1,774)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-08-18 Purchase : show line 1 in the form +11,340 $0.13 $1,474 7,158,542 D
2016-08-18 Purchase : show line 2 in the form +2,000 $0.15 $300 7,160,542 D
Open-market purchases · 13,340 sh · avg $0.13 · $1,774
Loading xslF345X03/primary_doc.xml…